John Hainsworth
Artificial Intelligence · 2004–2019
A researcher in the Science corpus: 11 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 15 citations into it
- Optimization & Training — 7 citations into it
- Computer Vision and Pattern Recognition — 5 citations into it
- Information Systems — 5 citations into it
Whom John Hainsworth trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from John Hainsworth's perspective
Ordered by how strongly the researchers John Hainsworth trusts endorse each paper. Same corpus, a different order for every researcher.
- Pegasos: primal estimated sub-gradient solver for SVM
- RCV1: A New Benchmark Collection for Text Categorization Research
- Pattern Recognition and Machine Learning
- Latent Dirichlet Allocation
- Optimizing search engines using clickthrough data
- Slow Learners are Fast
- Indexing by Latent Semantic Analysis
- Efficient Large-Scale Distributed Training of Conditional Maximum Entropy Models
- Parallelized Stochastic Gradient Descent
- Solving large scale linear prediction problems using stochastic gradient descent algorithms
Their papers
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (2004) — 9,988 citations
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma (2012) — 1,358 citations
- Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study (2019)
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (2018) — 1,089 citations
- Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study. (2015) — 747 citations
- Increased survival with enzalutamide in prostate cancer after chemotherapy. (2012) — 4,361 citations
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. (2011) — 946 citations
- Abiraterone and Increased Survival in Metastatic Prostate Cancer (2011) — 4,290 citations
- Detecting adversarial advertisements in the wild (2011) — 110 citations
- Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. (2008) — 602 citations
- Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. (2005) — 708 citations